tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NVS Stock Latest News

Novartis upgraded to Overweight from Neutral at JPMorgan
The FlyNovartis upgraded to Overweight from Neutral at JPMorgan
4h ago
NVS
Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
PremiumThe Fly
Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
3d ago
F
GM
Salesforce (CRM) Wins AstraZeneca Deal, Becomes the Unified Global Platform
PremiumMarket News
Salesforce (CRM) Wins AstraZeneca Deal, Becomes the Unified Global Platform
4d ago
AZN
CRM
FDA shift in drug study requirements sends trial runners lower
PremiumThe Fly
FDA shift in drug study requirements sends trial runners lower
4d ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
PremiumThe Fly
FDA to reduce number of trials required for drug approvals, STAT reports
4d ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
PremiumThe FlyFDA to reduce number of trials required for drug approvals, STAT reports
4d ago
AZN
BMY
Novartis price target raised to $143 from $136 at Morgan Stanley
Premium
The Fly
Novartis price target raised to $143 from $136 at Morgan Stanley
5d ago
NVS
Is AstraZeneca’s Stock (AZN) a Good Investment Right Now?
Premium
Market News
Is AstraZeneca’s Stock (AZN) a Good Investment Right Now?
6d ago
AZN
BMY
Top drug regulator Richard Pazdur preparing to exit FDA, STAT News reports
PremiumThe Fly
Top drug regulator Richard Pazdur preparing to exit FDA, STAT News reports
6d ago
AZN
BMY
Vaccine committee considers changes to childhood schedule, NY Times reports
PremiumThe Fly
Vaccine committee considers changes to childhood schedule, NY Times reports
6d ago
AZN
BMY
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
PremiumThe Fly
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
7d ago
B
BX
Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing
PremiumThe Fly
Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing
7d ago
AZN
BMY
US government confirms agreement in principle with UK on pharmaceutical pricing
PremiumThe FlyUS government confirms agreement in principle with UK on pharmaceutical pricing
7d ago
AZN
BMY
US, UK expected to agree on zero-tariffs pharmaecuticals deal, UK Times says
Premium
The Fly
US, UK expected to agree on zero-tariffs pharmaecuticals deal, UK Times says
7d ago
AZN
BMY
Novartis Gains FDA Approval for Groundbreaking SMA Gene Therapy
Premium
Company Announcements
Novartis Gains FDA Approval for Groundbreaking SMA Gene Therapy
13d ago
6K
NVS
Novartis upgraded to Buy from Neutral at BofA
PremiumThe Fly
Novartis upgraded to Buy from Neutral at BofA
13d ago
NVS
Novartis AG: Strong Growth Potential Amid Patent Expirations with Robust Pipeline and Strategic Phase III Trials
PremiumRatings
Novartis AG: Strong Growth Potential Amid Patent Expirations with Robust Pipeline and Strategic Phase III Trials
13d ago
NVS
Novartis receives FDA approval for Itvisma
PremiumThe Fly
Novartis receives FDA approval for Itvisma
14d ago
NVS
Labcorp appoints Victor Bulto to Board of Directors
PremiumThe Fly
Labcorp appoints Victor Bulto to Board of Directors
14d ago
LH
NVS
Morning Movers: Walmart gains, Bath & Body Works plummets after Q3 reports
PremiumThe FlyMorning Movers: Walmart gains, Bath & Body Works plummets after Q3 reports
18d ago
J
ABT
Novartis sees +5%-6% sales CAGR cc for 2025-2030
Premium
The Fly
Novartis sees +5%-6% sales CAGR cc for 2025-2030
18d ago
NVS
Novartis Projects Strong Growth with Updated Sales Guidance and Strategic Acquisitions
Premium
Company Announcements
Novartis Projects Strong Growth with Updated Sales Guidance and Strategic Acquisitions
18d ago
6K
NVS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >